DPYSL2 and ovarian carcinoma: Further analysis revealed that FER phosphorylated CRMP2 in ovarian cancer cells since FER inhibition or depletion decreased total CRMP2 tyrosine phosphorylation in the ovarian cancer cell lines OVCA432 or SKOV3 (Supplementary Fig. 3b, c).